newsfilter
← Latest News
FDA Approved Drugs·

Approval of Imdelltra, Bla #761344

Approval Date: 09/11/2026; Drug Name: Imdelltra, Bla #761344; Active Ingredients: TARLATAMAB-DLLE; Company: Amgen Inc; Submission Status: Approval; Application Number: 761344

Company
AMGEN INC
Keywords
AMGEN INC